Benchmark restated their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a report issued on Thursday morning, Benzinga reports. Benchmark currently has a $5.00 target price on the stock. Separately, HC Wainwright reissued a buy rating and set a $7.00 price objective on shares of Clene in a research note on Wednesday, […]